Chemotherapy: Chemo can be given before and/or after surgery. HER2 targeted drugs: Some women with HER2-positive cancers will be treated with adjuvant (after surgery) chemotherapy with trastuzumab with or without pertuzumab for up to 1 year. Many women with HER2-positive cancers will be treated first with trastuzumab (with or without pertuzumab
HER2-targeted therapies and HER2-positive breast cancer. HER2-positive breast cancers have a lot of a protein called HER2 on the surface of their cells. The HER2 protein is an important driver of cell growth and survival. HER2-targeted therapies are designed to treat HER2-positive breast cancers.
Trastuzumab is an antibody drug specially made to target HER2-positive cancer cells. Trastuzumab attaches to the HER2 protein on the surface of HER2-positive
Margenza (margetuximab): This monoclonal antibody drug may be used in combination with chemo for metastatic HER2-positive breast cancers
Monoclonal antibody drugs such as Herceptin (also known as Trastuzumab) target HER2-positive tumors. If cancer cells are positive for the HER2
Margenza (margetuximab): This monoclonal antibody drug may be used in combination with chemo for metastatic HER2-positive breast cancers
Image of a woman with long dark hair. Chemo, Targeted Drugs Extremely Efficacious in HER2-Positive Breast Cancer Side Effects to Know
Skin CancerSkin Cancer Thyroid Cancer. Spotlight -. Blogs Chemo, Targeted Drugs Extremely Efficacious in HER2-Positive Breast Cancer.
LeukemiaLeukemiaLeukemia Image of a woman with long dark hair. Chemo, Targeted Drugs Extremely Efficacious in HER2-Positive Breast Cancer.
Comments